search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
The Big Picture THE BIG PICTURE: INVESTORS BANK ON EMERGING MARKET RECOVERY


DEMAND FOR EM STOCKS SURGES


100 200 300 400 500 600 700


0


Net returns (USD)


Source: MSCI


Emerging market stocks reported record inflows towards the end of 2020, driven by Covid vaccine approvals. Mona Dohle takes a look behind the headlines.


Investors are fickle creatures. Following strong outflows from emerging markets in the Spring, their fortunes turned when news broke of the first rollout of a Covid vaccine. Emerging market equities were the key beneficiaries, reporting record level inflows. By the end of November, portfolio inflows into emerging mar- kets stood at $76.5bn (£56.6bn), with equity markets account- ing for more than half at $39.8bn (£29.4bn), according to the Institute of International Finance. The MSCI Emerging Mar- ket index surged to 581.39 basis points by the end of November, its highest level in 20 years (see graph).


Investors are particularly bullish on the recovery of the Asian and Latin American markets, while the outlook for Europe, the


12 | portfolio institutional December–January 2021 | issue 99


Middle East and Africa (EMEA) remains more cautious, according to a Bloomberg survey.


There is a catch to the sudden risk-on mood. The efficient roll- out of a Covid vaccine is seen as a key driver of investor opti- mism, according to Bloomberg. But vaccine producers have reported that Western governments have already pre-ordered most of the available supply for the next few years, according to market analytics firm Airfinity. Canada leads the race by secured enough vaccines to inoculate its entire population four times over, followed by the US, UK and EU, who have snatched up the bulk of the world’s vaccine supply. Meanwhile, major emerging markets, including Brazil, Indone- sia, Mexico, Thailand and Turkey, have only been able to reserve enough to vaccinate about half of their population, while the remainder of Latin America has vaccine reservations for a third of its citizens throughout the next year, according to Airfinity, a potential stumbling block for emerging market recovery.


Dec 01, 2000 Aug 01, 2001 Apr 01, 2002 Dec 01, 2002 Aug 01, 2003 Apr 01, 2004 Dec 01, 2004 Aug 01, 2005 Apr 01, 2006 Dec 01, 2006 Aug 01, 2007 Apr 01, 2008 Dec 01, 2008 Aug 01, 2009 Apr 01, 2010 Dec 01, 2010 Aug 01, 2011 Apr 01, 2012 Dec 01, 2012 Aug 01, 2013 Apr 01, 2014 Dec 01, 2014 Aug 01, 2015 Apr 01, 2016 Dec 01, 2016 Aug 01, 2017 Apr 01, 2018 Dec 01, 2018 Aug 01, 2019 Apr 01, 2020


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60